Citadel Advisors
IFRX icon

Citadel Advisors’s InflaRx IFRX Stock Holding History

Citadel Advisors’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Sell
50,900
-5,500
-10% -$10.3K ﹤0.01% 12592
2026
Q1 		$50.4K Sell
56,400
-38,100
-40% -$36K ﹤0.01% 12401
2025
Q4 		$95.4K Buy
94,500
+42,500
+82% +$52.8K ﹤0.01% 11680
2025
Q3 		$69.7K Buy
52,000
+19,300
+59% +$20.5K ﹤0.01% 12038
2025
Q2 		$25.8K Sell
32,700
-900
-3% -$1.06K ﹤0.01% 12043
2025
Q1 		$34.3K Buy
33,600
+2,700
+9% +$5.09K ﹤0.01% 12687
2024
Q4 		$76.3K Buy
30,900
+11,600
+60% +$22.3K ﹤0.01% 11845
2024
Q3 		$29.5K Buy
19,300
+14,100
+271% +$21.5K ﹤0.01% 12454
2024
Q2 		$9.05K Sell
5,200
-7,700
-60% -$11.3K ﹤0.01% 13155
2024
Q1 		$19.9K Hold
12,900
– – ﹤0.01% 13021
2023
Q4 		$21K Sell
12,900
-5,700
-31% -$9.77K ﹤0.01% 12582
2023
Q3 		$55.4K Buy
18,600
+10,800
+138% +$41.1K ﹤0.01% 11637
2023
Q2 		$34.8K Sell
7,800
-5,400
-41% -$24.2K ﹤0.01% 12201
2023
Q1 		$25.6K Sell
13,200
-3,400
-20% -$7.34K ﹤0.01% 12869
2022
Q4 		$51.5K Sell
16,600
-13,900
-46% -$35.4K ﹤0.01% 12100
2022
Q3 		$81K Buy
+30,500
New +$68.7K ﹤0.01% 11271
2022
Q2 		– Sell
-18,000
Closed -$33K – 13425
2022
Q1 		$33K Sell
18,000
-21,900
-55% -$68.2K ﹤0.01% 13051
2021
Q4 		$190K Buy
39,900
+5,100
+15% +$20.5K ﹤0.01% 11921
2021
Q3 		$90K Buy
+34,800
New +$91.7K ﹤0.01% 12976
2020
Q4 		– Sell
-17,900
Closed -$76K – 11192
2020
Q3 		$76K Buy
17,900
+7,300
+69% +$33.6K ﹤0.01% 9422
2020
Q2 		$49K Buy
+10,600
New +$68.7K ﹤0.01% 9314

Other funds holding IFRX

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Citadel Advisors's IFRX Position: Q2 2026 in Review

Citadel Advisors increased its InflaRx (IFRX) stake by 435% in Q2 2026, buying an estimated $213K and bringing the position to 139,290 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #11026.

Citadel Advisors first reported a position in IFRX in Q1 2018 and has held it in 26 quarters since. The position peaked at $6.13M in Q2 2018. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Citadel Advisors held 139,290 shares of InflaRx worth $312K as of Q2 2026.
  • Citadel Advisors bought 113,253 InflaRx shares in Q2 2026, an estimated $213K.
  • InflaRx made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11026 holding.
  • Citadel Advisors first reported a position in InflaRx in Q1 2018 and has held it in 26 quarters since.
  • Citadel Advisors's InflaRx position peaked at $6.13M in Q2 2018.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.